Flavoxate PCD Pharma Franchise Company
Cafoli Lifecare offers a Flavoxate PCD pharma franchise built on 4 tablet formulations manufactured at WHO-GMP certified facilities. This gives franchise partners a focused urology line for the management of urinary bladder symptoms.
What is Flavoxate?
Flavoxate is a urinary antispasmodic that relaxes the smooth muscle of the urinary tract through a direct spasmolytic action along with anticholinergic and local anaesthetic effects. This eases bladder spasm and the associated urgency and pain. Read its profile on PubChem.
Therapeutic Applications
Flavoxate is prescribed to relieve dysuria, urinary frequency, urgency, nocturia and suprapubic pain arising from cystitis, prostatitis, urethritis and urethrocystitis, and to control bladder spasm after urological procedures or catheterisation. Prescriptions come mainly from urologists, gynaecologists and general physicians.
Why Flavoxate is a High-Potential Molecule for Distributors
Urinary tract infections and irritative bladder symptoms are extremely common — especially among women and older men — and flavoxate is a standard symptomatic add-on prescribed alongside antibiotics for painful, spasm-related urinary complaints. That reliable co-prescription pattern gives it steady, recurring turnover in urology and general practice, making it a dependable supporting molecule for distributors.
Why Choose Cafoli Lifecare
Cafoli Lifecare provides territory-wise monopoly rights, WHO-GMP certified manufacturing, DCGI-approved formulations, complete promotional inputs and the backing of 1000+ franchise partners across India.
References
- PubChem: Flavoxate
- PubMed: Flavoxate literature
Our formulations of Flavoxate find application in many critical therapeutic areas. Its therapeutic spectrum includes, but is not limited to: